Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 80

Results For "Biotech"

905 News Found

Glenmark subsidiary, Ichnos Sciences and Almirall enter exclusive licencing agreement
Biotech | December 14, 2021

Glenmark subsidiary, Ichnos Sciences and Almirall enter exclusive licencing agreement

Ichnos will receive an upfront payment of Euro 20.8 million as well as additional development and commercial milestone payments and tiered royalties based upon future global sales


ICMR Dibrugarh designs kit to detect Omicron variant in two hours
News | December 13, 2021

ICMR Dibrugarh designs kit to detect Omicron variant in two hours

GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model


KOREA PACK and ICPI to be held in June 2022 in hybrid format
Packaging | December 13, 2021

KOREA PACK and ICPI to be held in June 2022 in hybrid format

KOREA PACK and concurrent event ICPI Week (Int’l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events in 2022


China approves Brii Bio’s antibody combination to neutralise Covid-19
Drug Approval | December 10, 2021

China approves Brii Bio’s antibody combination to neutralise Covid-19

Brii Bio announces amubarvimab/romlusevimab combination received approval from NMPA


Venair showcases its Vena Flexip and Flexpure
Medical Device | December 08, 2021

Venair showcases its Vena Flexip and Flexpure

The company plans to expand their capacity to meet the needs of pharma and biotech industries


Olympus lays out its plans for growth in the medical business
Digitisation | December 08, 2021

Olympus lays out its plans for growth in the medical business

Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected


RDIF offers vaccine for adolescents aged 12-17 in India
News | December 07, 2021

RDIF offers vaccine for adolescents aged 12-17 in India

Sputnik M is a new member of the Sputnik vaccines family


Study shows Glaxo-Vir drug works against Omicron mutations
News | December 07, 2021

Study shows Glaxo-Vir drug works against Omicron mutations

Data builds on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19


Monthly production capacity of Covishield and Covaxin touches 90% : Govt
News | December 05, 2021

Monthly production capacity of Covishield and Covaxin touches 90% : Govt

Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million


Apollo Health Ventures closes US $ 180 million fund
Startup | December 05, 2021

Apollo Health Ventures closes US $ 180 million fund

The fund aims at investing in companies that extends human healthspan